Versiti is collecting plasma from recovered COVID-19 patients to help treat others diagnosed with the virus.
This blood-related treatment – approved by the FDA as an Emergency Investigational New Drug (EIND) – could offer hope to the hundreds of patients who continue to be diagnosed. This treatment would be used by hospitals for the most severely affected patients. Participants must be eligible to donate blood – see eligibility here.
Potential convalescent plasma donors must:
- Have had a confirmed diagnosis of COVID-19 by physician and laboratory testing
- Must be symptom free for 14 days before being eligible to donate
Frequently Asked Questions: see FDA.gov Investigational COVID-19 Convalescent Plasma Emergency INDs
If you or your patient qualify as a COVID-19 convalescent plasma donor, please submit the form below with appropriate paperwork if available. A coordinator in your state will be in contact soon.
Contact Us About Convalescent Plasma Donation